Log in to save to my catalogue

Measurement of salivary adrenal-specific androgens as biomarkers of therapy control in 21-hydroxylas...

Measurement of salivary adrenal-specific androgens as biomarkers of therapy control in 21-hydroxylas...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2267011967

Measurement of salivary adrenal-specific androgens as biomarkers of therapy control in 21-hydroxylase deficiency

About this item

Full title

Measurement of salivary adrenal-specific androgens as biomarkers of therapy control in 21-hydroxylase deficiency

Publisher

United States: Copyright Oxford University Press

Journal title

The journal of clinical endocrinology and metabolism, 2019-12, Vol.104 (12), p.6417-6429

Language

English

Formats

Publication information

Publisher

United States: Copyright Oxford University Press

More information

Scope and Contents

Contents

Monitoring of hormonal control represents a key part of the management of congenital adrenal hyperplasia (CAH). Monitoring strategies remain suboptimal because they rely on frequent blood tests and are not specific for adrenal-derived hormones. Recent evidence suggests the crucial role of adrenal-specific 11-oxygenated-C19 androgens in the pathogen...

Alternative Titles

Full title

Measurement of salivary adrenal-specific androgens as biomarkers of therapy control in 21-hydroxylase deficiency

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_miscellaneous_2267011967

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_2267011967

Other Identifiers

ISSN

0021-972X

E-ISSN

1945-7197

DOI

10.1210/jc.2019-00031

How to access this item